Churg-Strauss syndrome occurring during omalizumab treatment
Yıl: 2015 Cilt: 2 Sayı: 3 Sayfa Aralığı: 129 - 130 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022
Churg-Strauss syndrome occurring during omalizumab treatment
Öz: -
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
- 2. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100. [CrossRef]
- 3. Lanham JG. Churg-Strauss syndrome. Br J Hosp Med 1992; 47: 667-73.
- 4. Watts RA, Carruthers DM, Scott DG. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995; 25: 28-34. [CrossRef]
- 5. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, et al. Benefits of omalizumab as addon therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005; 60: 309-16. [CrossRef]
- 6. Winchester DE, Jacob A, Murphy T. Omalizumab for asthma. N Engl J Med 2006; 355: 1281-2. [CrossRef]
- 7. Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J. Administration of anti-IgE to a ChurgStrauss syndrome patient. Int Arch Allergy Immunol 2007; 144: 155-8. [CrossRef]
- 8. Bargagli E, Rottoli P. Omalizumab treatment associated with Churg-Strauss vasculitis. Int Arch Allergy Immunol 2008; 145: 268. [CrossRef]
- 9. Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L. Churg-strauss syndrome in patients treated with omalizumab. Chest 2009; 136: 507-18. [CrossRef]
| APA | Bekçibaşı M, Barutcu S, CELEN M, DAYAN S, HOŞOĞLU S (2015). Churg-Strauss syndrome occurring during omalizumab treatment. , 129 - 130. |
| Chicago | Bekçibaşı Muhammed,Barutcu Sezgin,CELEN MUSTAFA,DAYAN Saim,HOŞOĞLU Salih Churg-Strauss syndrome occurring during omalizumab treatment. (2015): 129 - 130. |
| MLA | Bekçibaşı Muhammed,Barutcu Sezgin,CELEN MUSTAFA,DAYAN Saim,HOŞOĞLU Salih Churg-Strauss syndrome occurring during omalizumab treatment. , 2015, ss.129 - 130. |
| AMA | Bekçibaşı M,Barutcu S,CELEN M,DAYAN S,HOŞOĞLU S Churg-Strauss syndrome occurring during omalizumab treatment. . 2015; 129 - 130. |
| Vancouver | Bekçibaşı M,Barutcu S,CELEN M,DAYAN S,HOŞOĞLU S Churg-Strauss syndrome occurring during omalizumab treatment. . 2015; 129 - 130. |
| IEEE | Bekçibaşı M,Barutcu S,CELEN M,DAYAN S,HOŞOĞLU S "Churg-Strauss syndrome occurring during omalizumab treatment." , ss.129 - 130, 2015. |
| ISNAD | Bekçibaşı, Muhammed vd. "Churg-Strauss syndrome occurring during omalizumab treatment". (2015), 129-130. |
| APA | Bekçibaşı M, Barutcu S, CELEN M, DAYAN S, HOŞOĞLU S (2015). Churg-Strauss syndrome occurring during omalizumab treatment. European Journal of Rheumatology, 2(3), 129 - 130. |
| Chicago | Bekçibaşı Muhammed,Barutcu Sezgin,CELEN MUSTAFA,DAYAN Saim,HOŞOĞLU Salih Churg-Strauss syndrome occurring during omalizumab treatment. European Journal of Rheumatology 2, no.3 (2015): 129 - 130. |
| MLA | Bekçibaşı Muhammed,Barutcu Sezgin,CELEN MUSTAFA,DAYAN Saim,HOŞOĞLU Salih Churg-Strauss syndrome occurring during omalizumab treatment. European Journal of Rheumatology, vol.2, no.3, 2015, ss.129 - 130. |
| AMA | Bekçibaşı M,Barutcu S,CELEN M,DAYAN S,HOŞOĞLU S Churg-Strauss syndrome occurring during omalizumab treatment. European Journal of Rheumatology. 2015; 2(3): 129 - 130. |
| Vancouver | Bekçibaşı M,Barutcu S,CELEN M,DAYAN S,HOŞOĞLU S Churg-Strauss syndrome occurring during omalizumab treatment. European Journal of Rheumatology. 2015; 2(3): 129 - 130. |
| IEEE | Bekçibaşı M,Barutcu S,CELEN M,DAYAN S,HOŞOĞLU S "Churg-Strauss syndrome occurring during omalizumab treatment." European Journal of Rheumatology, 2, ss.129 - 130, 2015. |
| ISNAD | Bekçibaşı, Muhammed vd. "Churg-Strauss syndrome occurring during omalizumab treatment". European Journal of Rheumatology 2/3 (2015), 129-130. |
